Fosfomycin Half-Life
The elimination half-life of fosfomycin in patients with normal renal function is approximately 5.7 hours after oral administration, but this increases substantially to 11-50 hours in patients with renal impairment, depending on the degree of dysfunction 1.
Normal Renal Function
In patients with normal kidney function, fosfomycin demonstrates predictable pharmacokinetics:
- Mean elimination half-life: 5.7 (± 2.8) hours following oral administration of fosfomycin tromethamine 1
- After intravenous administration, the half-life is slightly shorter at approximately 3.4 hours 2
- The drug is rapidly absorbed with peak serum concentrations (Cmax) of 26.1 mcg/mL achieved within 2 hours under fasting conditions 1
The relatively short half-life in normal renal function reflects the drug's primary elimination pathway through the kidneys, with approximately 38% of an oral dose recovered unchanged in urine 1.
Impact of Renal Impairment
Renal dysfunction dramatically prolongs fosfomycin's half-life due to decreased renal clearance:
Moderate to Severe Renal Impairment
- In patients with creatinine clearances ranging from 54 mL/min to 7 mL/min, the half-life increases from 11 hours to 50 hours 1
- The percent of fosfomycin recovered in urine decreases from 32% to 11%, confirming that renal impairment significantly reduces drug excretion 1
- In elderly patients with impaired renal function (mean creatinine clearance 40 mL/min), elimination half-lives ranged between 7 to 24 hours 3
End-Stage Renal Disease (ESRD)
- In anuric patients undergoing hemodialysis, the half-life extends to 40 hours during hemodialysis 1
- This represents nearly an 8-fold increase compared to patients with normal renal function
Clinical Implications
Despite the prolonged half-life in renal impairment, urinary concentrations remain therapeutically adequate:
- Even in elderly patients with impaired renal function, urinary fosfomycin concentrations exceeded 165 mg/L between 36-48 hours after a single 3-gram dose 3
- These levels remain well above the minimum inhibitory concentration (MIC) for common uropathogens for at least 48 hours 3
- Urinary concentrations remain above 100 mcg/mL regardless of the degree of renal insufficiency 4
No dose adjustment is necessary for elderly patients with creatinine clearances above 50 mL/min per 1.73 m² 5. However, in critically ill patients receiving continuous renal replacement therapy (CRRT), the pharmacokinetics change substantially, and higher doses (15-16 grams daily across 3-4 doses) may be required 6.
Important Caveat
The half-life values cited reflect oral fosfomycin tromethamine formulation. The calcium salt formulation shows even longer elimination half-lives (11.80 ± 6.86 hours in elderly subjects) due to poorer intestinal absorption and delayed absorption kinetics 5.